Ticamet

Ticamet

Dry Powder Inhalation Capsule (DPI)

🧬 Salmeterol + Fluticasone Propionate 🏢 Square Pharmaceuticals PLC
Generic Name Salmeterol + Fluticasone Propionate
Manufacturer Square Pharmaceuticals PLC
Unit Price Unit Price: ৳ 12.03 (8 x 6: ৳ 577.44) Strip Price: ৳ 72.18

🔹 Indications

Ticamet is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
  • Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
  • Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.

🔹 Pharmacology

Ticamet is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
  • Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
  • Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.

🔹 Dosage & Administration

Ticamet is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
  • Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
  • Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.

🔹 Interaction

Ticamet is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
  • Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
  • Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.

🔹 Contraindications

Ticamet is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
  • Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
  • Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.

🔹 Side Effects

Ticamet is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
  • Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
  • Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.

🔹 Pregnancy & Lactation

Ticamet is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
  • Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
  • Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.

🔹 Precautions & Warnings

Ticamet is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
  • Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
  • Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.

🔹 Pediatric Usage

Ticamet is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
  • Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
  • Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.

🔹 Storage Conditions

Ticamet is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
  • Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
  • Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.

💡 Frequently Asked Questions

Ticamet is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate: Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled sh...
Ticamet is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate: Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled sh...
Ticamet is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate: Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled sh...

User Reviews

No reviews yet!
Be the first to share your experience.

Write a Review